Express

A16z Makes First Investment in "DeSci" with Decentralized Biobank Platform AminoChain

Shawn

Summary: Venture capital firm Andreessen Horowitz (a16z) has made its first investment in decentralized science (DeSci) by leading a $5 million seed round for AminoChain, a decentralized biobank platform. AminoChain aims to enhance ownership, transparency, and consent in medical data collection through blockchain technology. The platform will allow medical institutions to share self-custodial data while preserving ...

Venture capital firm Andreessen Horowitz (a16z) has made its first investment in decentralized science (DeSci) by leading a $5 million seed round for AminoChain, a decentralized biobank platform.

AminoChain aims to enhance ownership, transparency, and consent in medical data collection through blockchain technology. The platform will allow medical institutions to share self-custodial data while preserving patient privacy, with the first application being a peer-to-peer marketplace for bio-samples.

Last Update:

Tags: ,,,
Link: A16z Makes First Investment in "DeSci" with Decentralized Biobank Platform AminoChain   [Copy]
Next:

Related Articles

  • GAEA Chat Singapore Concludes Successfully - A Recap of the Industry Thought Feast Duri... 12 days ago
  • U.S. SEC Clears Path for Institutional Crypto Custody, Recognizing State Trust Companie... 16 days ago
  • BTC Weekly Watch: Is the Rebound "Feast" Nearing Its End? September 16, 2025
  • ​The Crypto Treasury Boom Meets Regulatory Chill: Is the DAT Frenzy Fading? September 9, 2025
  • Nasdaq Takes Aim at 'Crypto-Flipping' Companies with Stricter Rules September 5, 2025

    • You need to login to comment.